112953 ⎘
Oligonucleotides characterized by their use Polymorphic or mutational markers
ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE
#1202HSD17B13 VARIANTS AND USES THEREOF
#1203PREDICTING RESISTANCE TO TILAPIA LAKE VIRUS
#1204Detection of Cancer in Urine
#1205APPARATUS AND METHOD FOR EARLY CANCER DETECTION AND CANCER PROGNOSIS USING A NANOSENSOR WITH RAMAN SPECTROSCOPY
#1206Biomarkers for predicting tumor response to and toxicity of immunotherapy
#1207HIGHLY SENSITIVE METHOD FOR DETECTING CANCER DNA IN A SAMPLE
#1208METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA IN TRANSPLANT RECIPIENTS OF MULTIPLE ORGANS
#1209METHODS, COMPOSITIONS, AND KITS FOR DETECTING ALLELIC VARIANTS
#1210Methods for Treating Multiple Myeloma
#1211METHODS AND COMPOSITIONS FOR TREATING 4- HYDROXYPHENYLPYRUVATE DIOXYGENASE-LIKE (HPDL)-RELATED DISEASES OR DISORDERS
#1212VISUAL DETECTION OF PBD INDUCED DNA CROSSLINKS
#1213THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS
#1214PROTEIN AND METABOLITE BLOOD BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME
#1215Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#1216COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CORONAVIRUS INFECTIONS
#1217METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION
#1218Compositions and methods for minimizing nornicotine synthesis in tobacco
#1219MELON VARIETY NUN 76520 MEM
#1220MELON VARIETY NUN 76221 MEM
#1221QUANTITATIVE TRAIT LOCI (QTLS) ASSOCIATED WITH A HIGH-VARIN TRAIT IN CANNABIS
#1222METHODS FOR DETECTING NUCLEIC ACID VARIANTS
#1223FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE
#1224Macrohaplotypes for Forensic DNA Mixture Deconvolution
#1225GENE EXPRESSION AND CELL-FREE DNA METHODS AND SYSTEMS FOR DISEASE DETECTION
#1226Apparatus and Methods for Analysis of Gene Mutation
#1227PANELS AND METHODS FOR TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA
#1228MULTIPLE-TIERED SCREENING AND SECOND ANALYSIS
#1229COMPOSITIONS AND METHODS FOR MUTATIONS ASSOCIATED WITH SUDDEN UNEXPECTED DEATH IN PEDIATRICS (SUDP)
#1230METHODS OF TREATING LIPEDEMA INCLUDING AKR1C2 AS A THERAPEUTIC TARGET
#1231CRISPR/CAS9 COMPLEX FOR GENOMIC EDITING
#1232Genetic locus imparting a low anatabine trait in tobacco and methods of using
#1233METHODS AND COMPOSITIONS FOR DNA BASED KINSHIP ANALYSIS
#1234GENERATION OF INDUCED PLURIPOTENT STEM CELL LINES FROM HUMAN PATIENTS WITH MUTATIONS IN THE GLUCOKINASE GENE
#1235METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION COMPRISING ENZYMES SUCH AS MURAMIDASE
#1236USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR TREATING CANCERS
#1237Semi-dominant molecular marker related to maize dwarf and application thereof
#1238METHODS, PROBE SETS, AND KITS FOR DETECTION OF DELETION OF TUMOR SUPPRESSOR GENES BY FLUORESCENCE IN SITU HYBRIDIZATION
#1239Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis
#1240SYSTEMS AND METHODS OF DIAGNOSING IDIOPATHIC PULMONARY FIBROSIS
#1241Detection and digital quantitation of multiple targets
#1242METHODS OF TREATING CANCER WITH POZIOTINIB
#1243METHOD OF TREATING POLYAMINE IMBALANCE-RELATED DISORDERS
#1244SYSTEM AND METHOD FOR GENERATING A GESTATIONAL DISORDER NOURISHMENT PROGRAM
#1245Methods for sequencing samples
#1246COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA
#1247P27 SINGLE-NUCLEOTIDE POLYMORPHISM T2871099G AS A PREDICTOR OF THE BENEFIT OF ENDOCRINE THERAPY ALONE OR IN COMBINATION WITH CDK INHIBITORS IN BREAST CANCER
#1248METHODS FOR DETECTING utDNA
#1249SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION
#1250METHOD OF TREATMENT WITH TRADIPITANT
#1251Method for parent-of-origin disease allele detection for the diagnosis and management of genetic diseases
#1252METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS
#1253MAGE-B2-SPECIFIC T-CELL RECEPTORS
#1254PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#1255Crenolanib for treating FLT3 mutated proliferative disorders relapsed/refractory to prior treatment
#1256METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER
#1257ANTHRACNOSE RESISTANT ALFALFA PLANTS
#1258DOWNY MILDEW RESISTANT LETTUCE PLANTS
#1259MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
#1260DETECTION OF SEQUENCES UNIQUELY ASSOCIATED WITH A DNA TARGET REGION
#1261C-RAF mutants that confer resistance to RAF inhibitors
#1262ALK FUSION GENES AND USES THEREOF
#1263METHODS AND BIOMARKERS IN CANCER
#1264METHODS RELATING TO ANTI-IL-1 THERAPY AND ANTI-IL-6 THERAPY AND HYPERSENSITIVITY
#1265METHOD FOR BARLEY HYBRID SEED PRODUCTION
#1266METHODS OF IDENTIFYING, SELECTING, AND PRODUCING SOUTHERN CORN RUST RESISTANT CROPS
#1267USE OF WEE1 KINASE INHIBITORS IN THE TREATMENT OF CANCER
#1268USE OF PYRIDO[1,2-A]PYRIMIDONE ANALOGUE
#1269NON R-GENE MEDIATED RESISTANCE
#1270CLUBROOT RESISTANCE IN BRASSICA
#1271COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL CANCERS TARGETING THE SIRPALPHA - CD47 INTERACTION
#1272SINGLE-STRANDED OLIGONUCLEOTIDE PROBES FOR CHROMOSOME OR GENE COPY ENUMERATION
#1273GENE COMBINATION FOR HUMAN TUMOR GRADING, AND USE THEREOF
#1274USE OF SIMULTANEOUS MARKER DETECTION FOR ASSESSING DIFUSE GLIOMA AND RESPONSIVENESS TO TREATMENT
#1275Extracellular mRNA Markers of Muscular Dystrophies in Human Urine
#1276GENETIC VARIANTS ASSOCIATED WITH LOCAL FAT DEPOSITION TRAITS FOR THE TREATMENT OF HERITABLE METABOLIC DISORDERS
#1277KIT FOR DETECTING MICROSATELLITE INSTABILITY AND METHOD THEREFOR
#1278METHODS AND COMPOSITIONS FOR INDUCING TUMOR CELL DEATH
#1279TRITICALE CULTIVAR APT1425621
#1280ALTERATION OF TOBACCO ALKALOID CONTENT THROUGH MODIFICATION OF SPECIFIC CYTOCHROME P450 GENES
#1281Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases
#1282Role of PVT1 in the Diagnosis and Treatment of MYC-Driven Cancer
#1283METHODS AND SYSTEMS FOR mRNA BOUNDARY ANALYSIS IN NEXT GENERATION SEQUENCING
#1284METHODS FOR IMPROVED CANCER TREATMENT
#1285METHOD FOR PREIMPLANTATION GENETIC SCREENING OF EMBRYOS FOR DETECTION OF STRUCTURAL REARRANGEMENTS
#1286METHOD FOR DETECTING PRESENCE OR PROPORTION OF DONOR IN RECEPTOR SAMPLE, AND KIT
#1287METHOD FOR DETECTING WHOLE TRANSCRIPTOME RNA STRUCTURE AND USE THEREOF
#1288INIR19 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS
#1289INHT20 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS
#1290PCR BUFFER COMPOSITION FOR INCREASING ACTIVITY OF DNA POLYMERASE WITH INCREASED GENE MUTATION SPECIFICITY
#1291NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#1292METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS
#1293Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof
#1294METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER
#1295METHOD OF MODIFYING GENOMIC DNA AND METHOD OF DETECTING MODIFICATION
#1296METHODS OF ANALYSIS OF ALLELIC EXPRESSION OF PIK3CA IN CANCER AND USES THEREOF
#1297METHODS AND COMPOSITIONS FOR DETECTING ESOPHAGEAL NEOPLASIAS AND/OR METAPLASIAS IN THE ESOPHAGUS
#1298MULTI-VECTOR DETECTION OF VARIANT SEQUENCES
#1299METHOD FOR DIAGNOSING AND TREATING SUBJECTS HAVING SINGLE NUCLEOTIDE POLYMORPHISMS IN CHROMOSOME 2, 2:107,510,000-107,540,000 LOCUS
#1300METHODS OF DETECTING HIGH RISK BARRETT'S ESOPHAGUS WITH DYSPLASIA, AND ESOPHAGEAL ADENOCARCINOMA
#1301DISEASE MARKER
#1302METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#1303METHODS TO PREDICT EFFECTS OF PERIOPERATIVE ADMINISTRATION OF METHADONE TO OPTIMIZE PAIN RELIEF AND AVOID ADVERSE EFFECTS
#1304Methods for accurate parallel detection and quantification of nucleic acids
#1305METHODS FOR NEXT GENERATION GENOME WALKING AND RELATED COMPOSITIONS AND KITS
#1306Methods to Quantify Rate of Clonal Expansion and Methods for Treating Clonal Hematopoiesis and Hematologic Malignancies
#1307Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#1308Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#1309USE OF MCM8-CGAS-STING-IFN-I SIGNAL PATHWAY AS DISEASE TARGET
#1310Compositions and methods for treating cancer
#1311DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION
#1312IGH REARRANGEMENTS AND USES THEREOF
#1313TREATMENT RESPONSE SIGNATURES
#1314DETECTION SYSTEM AND DETECTION METHOD OF GENOMIC CARCINOGENESIS INFORMATION BASED ON CELL-FREE DNA
#1315METHODS, SYSTEMS AND APPARATUS FOR COPY NUMBER VARIATIONS AND SINGLE NUCLEOTIDE VARIATIONS SIMULTANEOUSLY DETECTED IN SINGLE-CELLS
#1316METHODS FOR AMPLIFICATION OF CELL-FREE DNA USING LIGATED ADAPTORS AND UNIVERSAL AND INNER TARGET-SPECIFIC PRIMERS FOR MULTIPLEXED NESTED PCR
#1317INIR11 TRANSGENIC MAIZE WITH JUNCTION SEQUENCE DELETIONS
#1318Methods of Treating Ovarian Cancer
#1319METHODS FOR IDENTIFYING AND SELECTING MAIZE PLANTS WITH CYTOPLASMATIC MALE STERILITY RESTORER GENE
#1320METHODS AND SYSTEMS FOR DETECTING AND QUANTIFYING LARGE NUMBER OF MOLECULE BIOMARKERS FROM A BODY FLUID SAMPLE
#1321TOMATO PLANTS HAVING FRUIT WITH HIGH ZEAXANTHIN CONTENT
#1322THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS FOR CANCER
#1323COMPOSITIONS AND METHODS FOR CHARACTERIZING LYMPHOMA AND RELATED CONDITIONS
#1324METHODS OF IDENTIFYING A TUMOR THAT IS SENSITIVE TO TREATMENT WITH TALAZOPARIB AND METHODS OF TREATMENT THEREOF
#1325METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS
#1326METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY
#1327METHOD FOR EARLY DETERMINATION OF GENDER BY MULTIPLEX PCR DETECTING FOUR GENES
#1328METHODS FOR CLASSIYING A SAMPLE INTO CLINICALLY RELEVANT CATEGORIES
#1329COMPOSITIONS AND METHODS TO INCREASE RESISTANCE TO PHYTOPHTHORA SOJAE IN SOYBEAN
#1330RNA PROBE FOR MUTATION PROFILING AND USE THEREOF
#1331PRECISION MEDICINE FOR CHOLESTEROL TREATMENT
#1332MARKER-ASSISTED BREEDING IN CANNABIS PLANTS
#1333NOVEL ENTEROVIRUS 71 MUTATIONS ASSOCIATED WITH DISEASE SEVERITY
#1334An SSR Marker For Detection Of Broad Bean Varieties Resistant To Broad Bean Weevil And Application Thereof
#1335SINGLE CELL SEQUENCING
#1336BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCERS
#1337METHOD FOR DETECTING COPY NUMBER OF SPECIFIC NUCLEIC ACID PER SINGLE CELL
#1338BIOMARKERS FOR MYELODYSPLASTIC SYNDROME (MDS) AND METHODS OF USING THE SAME
#1339BIOMARKERS FOR CONFORMATION OF RIDING TRAITS IN HORSES
#1340METHOD FOR TRACEABLE MEDIUM-THROUGHPUT SINGLE-CELL COPY NUMBER SEQUENCING
#1341BARCODING SYSTEMS AND METHODS FOR GENE SEQUENCING AND OTHER APPLICATIONS
#1342MARKER ASSOCIATED WITH SMUT RESISTANCE IN PLANT BELONGING TO GENUS SACCHARUM AND USE THEREOF
#1343Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments
#1344CANCER EXAMINATION METHOD AND CANCER TREATMENT AGENT
#1345METHOD FOR SELECTING ANTIGENIC VIRAL SEQUENCES FOR VACCINES AND THERAPEUTICS
#1346SOYBEAN TRANSGENIC EVENT GM_CSM63770 AND METHODS FOR DETECTION AND USES THEREOF
#1347ASSAY FOR TRICHOMONAS VAGINALIS BY AMPLIFICATION AND DETECTION OF TRICHOMONAS VAGINALIS AP65-1 GENE
#1348HIGHLY POLYMORPHIC AND MODULAR EXTRAGENIC (H.P.M.E.) MARKERS WITHIN SPECIFIC TAXA OF MICROORGANISMS AND USE THEREOF FOR THEIR DIFFERENTIATION, IDENTIFICATION AND QUANTIFICATION
#1349METHOD AND KIT FOR TESTING DRUG HYPERSENSITIVITY REACTIONS CAUSED BY SULFONAMIDE DERIVATIVE-BASED ANTIEPILEPTIC DRUG AND USE OF THE KIT
#1350METHOD FOR NUCLEIC ACID AMPLIFICATION
#1351METHODS AND SYSTEMS OF STRATIFYING INFLAMMATORY DISEASE PATIENTS
#1352NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#1353TREATMENTS FOR MUTATIONS IN ACUTE MYELOID LEUKEMIA
#1354Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VEGF
#1355Computational modeling of loss of function based on allelic frequency
#1356METHODS OF DETECTING SYNTHETIC URINE AND MATCHING A URINE SAMPLE TO A SUBJECT
#1357SYSTEM AND METHOD FOR CHARACTERIZATION AND LABELING OF PLANT VARIETIES
#1358METHODS AND COMPOSITIONS USEFUL IN DISCRIMINATING BETWEEN FISH SPECIES
#1359HOMOLOGOUS RECOMBINATION DEFICIENCY DETERMINING METHOD AND KIT THEREOF
#1360BCL10 MUTATIONS AS BIOMARKERS FOR TARGETED THERAPY IN B CELL LYMPHOMAS
#1361Methods and systems for analyzing nucleic acid molecules
#1362Method for Determining Sensitivity to an Antineoplastic Agent
#1363APPLICATION OF VARIATIONS IN NOTCH FAMILY GENES IN PREDICTING SENSITIVITY TO IMMUNE CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH SOLID TUMORS
#1364METHODS OF DETECTING CELL-FREE DNA IN BIOLOGICAL SAMPLES
#1365GENETIC VARIATIONS ASSOCIATED WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO
#1366SINGLE NUCLEOTIDE POLYMORPHISM MARKER FOR PREDICTING RISK OF ALZHEIMERS DISEASE AND USE THEREOF
#1367DETECTING METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH THROUGHPUT SEQUENCING
#1368Compositions and Methods for Assessing DNA Damage in a Library and Normalizing Amplicon Size Bias
#1369Multiplex Assay for Simultaneous Detection of Equine Group A and B Rotaviruses and Genotyping of Equine Rotavirus A G3 And G14
#1370POLYMORHPISM DETECTION FOR GLIOBLASTOMA DETECTION AND TREATMENT
#1371NOVEL BIOMARKER FOR PREDICTING PROGNOSIS OF TREATMENT OF HER2-POSITIVE BREAST CANCER AND USE THEREOF
#1372MITOCHONDRIAL DNA PROSTATE CANCER MARKER AND RELATED SYSTEMS AND METHODS
#1373DNA Copy Number Alterations (CNAs) to Determine Cancer Phenotypes
#1374MEANS AND METHODS FOR ACCURATELY ASSESSING CLONAL IMMUNOGLOBULIN (IG)/T CELL RECEPTOR (TR) GENE REARRANGEMENTS
#1375A GENE ASSOCIATED WITH HUMAN READING PERFORMANCE
#1376METHODS TO DETECT A SILENT CARRIER GENOTYPE
#1377Methods and systems for detecting genetic variants
#1378INIR4 TRANSGENIC MAIZE
#1379INIR17 TRANSGENIC MAIZE
#1380FGFR2 INHIBITORS FOR THE TREATMENT OF CHOLANGIOCARCINOMA
#1381BACTERIAL BIOMARKER FOR RHEUMATOID ARTHRITIS AND RELATED MATERIALS AND METHODS
#1382USE OF CIRCULATING CELL-FREE RNA FOR DIAGNOSIS AND/OR MONITORING CANCER
#1383COMPOSITION FOR DIAGNOSIS OR PREDICTION OF METABOLIC SYNDROME OR GROUP AT HIGH RISK OF EXPRESSION OF BLOOD CERAMIDE
#1384A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS
#1385METHODS FOR PREVENTING OR REDUCING ACUTE KIDNEY INJURY
#1386SINGLE POINT VARIANT DETECTION
#1387SYSTEMS AND METHODS FOR PREDICTING THERAPY EFFICACY FROM NORMALIZED BIOMARKER SCORES
#1388INSTANT NUCLEIC ACID TEST METHOD AND TEST KIT FOR PATHOGENIC MUTANTS
#1389METHOD FOR DETECTING POLYNUCLEOTIDE VARIATIONS
#1390CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS
#1391GRAPHENE-BASED BIOSENSOR AND DETECTION METHOD USING SAME
#1392METHOD FOR PREIMPLANTATION GENETIC SCREENING OF EMBRYOS
#1393METHOD FOR PREDICTING PATIENT RESPONSE TO CD40-TARGETED THERAPIES
#1394SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER
#1395METHOD
#1396USE OF BRAIN ORGANOIDS AND SINGLE CELL GENOMICS TO UNDERSTAND AND TREAT NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS
#1397GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS
#1398INCREASING PHOTOSYNTHETIC CAPACITY IN PLANTS
#1399INSECT RESISTANT INIR6 TRANSGENIC MAIZE PLANTS LACKING A SELECTABLE MARKER AND JUNCTION
#1400METHODS AND KITS FOR IDENTIFYING SUBJECTS RESPONSIVE TO ARGININE DEPRIVATION THERAPY
#1401METHODS FOR SELECTING MEDICATIONS
#1402METHOD FOR DETECTING HUMAN MICROSATELLITE INSTABILITY SITE, AND USE THEREOF
#1403METHOD FOR PREDICTING RESPONSIVENESS TO PLK1 INHIBITION
#1404EML4-ALK translocations in lung cancer
#1405COMPREHENSIVE GENOMIC PROFILING (CGP) OF METASTATIC INVASIVE LOBULAR CARCINOMAS REVEALS HETEROGENEITY
#1406TARGET-ENRICHED MULTIPLEXED PARALLEL ANALYSIS FOR ASSESSMENT OF FETAL DNA SAMPLES
#1407USE OF KLK5 ANTAGONISTS FOR THE TREATMENT OF A DISEASE
#1408SYSTEMS FOR THE DETECTION OF TARGETED GENE VARIATIONS AND VIRAL GENOMES AND METHODS OF PRODUCING AND USING SAME
#1409Method for Detecting Genetic Polymorphism
#1410MODULATION OF GENE EXPRESSION AND SCREENING FOR DEREGULATED PROTEIN EXPRESSION
#1411INTESTINAL EXPRESSION OF PROGRAMMED DEATH LIGAND 1
#1412TISSUE KALLIKREIN-1 FOR TREATING CHRONIC KIDNEY DISEASE
#1413PREDICTIVE PESTICIDE RESISTANCE MAP GENERATION AND USE
#1414Compositions and methods for assaying proteins and nucleic acids
#1415METHOD FOR SELECTING OR IDENTIFYING A BRASSICA NAPUS PLANT HAVING RESISTANCE TO FUNGAL PATHOGEN
#1416METHODS OF GENOTYPING CANNABIS
#1417Methods for sequencing samples
#1418METHOD FOR DIAGNOSING CANCER AND PREDICTING TYPE OF CANCER BASED ON SINGLE NUCLEOTIDE VARIANT IN CELL-FREE DNA
#1419ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
#1420METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1421METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1422METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1423METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1424METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1425MARKERS OF TISSUE AGING AND USES THEREFOR
#1426TERPENE-BASED COMPOSITIONS, METHODS OF PREPARATIONS AND USES THEREOF
#1427STRATIFICATION METHODS FOR ASSESSING THE PROGRESSION AND RISK OF ADVANCED COLORECTAL ADENOMA AND COLORECTAL CANCER
#1428METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1429METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1430METHODS OF MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
#1431TARGETED SEQUENCING METHOD AND KIT THEREOF FOR DETECTING GENE ALTERATION
#1432METHODS AND MATERIALS FOR TREATING HEART FAILURE
#1433Method to Produce Cannabis Haploid Plants and Consequent Spontaneous or Chemically Induced Haploid/Di-Haploid in a Single Generation
#1434COMPOSITIONS AND METHODS FOR TUMOR CHARACTERIZATION
#1435METHODS OF DETECTING GENOMIC REARRANGEMENTS USING CELL FREE NUCLEIC ACIDS
#1436METHODS OF TREATMENT AND DIAGNOSIS OF PARKINSON'S DISEASE ASSOCIATED WITH WILD-TYPE LRRK2
#1437BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF FIBROTIC LUNG DISEASE
#1438METHODS OF SEQUENCING INDIVIDUAL VIRAL GENOMES
#1439Dynamic changes in circulating free RNA of neural tumors
#1440CANCER TREATMENTS AND METHODS OF SELECTING SAME
#1441METHODS TO PREDICT OUTCOMES TO CHIMERIC ANTIGEN RECEPTOR T-CELLS IN LYMPHOMA FROM CELL-FREE DNA AND GENETIC MUTATIONS
#1442BIOMARKERS FOR PREDICTING RESPONSIVENESS TO MEK INHIBITOR MONOTHERAPY AND COMBINATION THERAPY
#1443METHODS FOR TREATMENT OF LUNG CANCERS
#1444Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
#1445Rare Variants In Hematopoietic Stem Cells (HSC) And Hematopoietic Progenitor Cells (HPC) Associated With Somatic Alterations Of The Blood
#1446METHODS OF ASSESSING RISK OF DEVELOPING A DISEASE
#1447METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#1448METHOD FOR PREDICTING POSSIBILITY OF BRAIN AMYLOID BETA ACCUMULATION
#1449METHODS AND COMPOSITIONS FOR IMPROVING YIELD TRAITS
#1450METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES
#1451METHODS OF DETECTING TUMOR PROGRESSION VIA ANALYSIS OF CELL-FREE NUCLEIC ACIDS
#1452GERMLINE BIOMARKERS OF CLINICAL RESPONSE AND BENEFIT TO IMMUNE CHECKPOINT INHIBITOR THERAPY
#1453BIOMARKERS FOR PREDICTING OVERALL SURVIVAL IN RECORRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
#1454APPLICATION OF RED BLOOD CELL NUCLEIC ACID IN IDENTIFYING TUMOR MUTATION TYPES
#1455PKD MUTATIONS AND EVALUATION OF SAME
#1456METHODS AND REAGENT FOR DIAGNOSING BIPOLAR DISORDER
#1457ONE OR MORE KINDS OF HLA GENE PRIMERS
#1458Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding IL33 And IL1RL1
#1459Methods of treating cholangiocarcinoma
#1460Systems and methods for analyzing viral nucleic acids
#1461RAPID AND LOW-COST NUCLEIC ACID DETECTION USING TRANSLATION-BASED SEQUENCE VERIFICATION ASSAYS
#1462GENETIC MARKERS FOR MYB28
#1463METHODS OF DETECTING RESIDUAL DISEASE AND TREATMENT THEREOF
#1464Kit for identifying malignancy, and uses thereof
#1465METHODS OF DETECTING AN INACTIVATING MUTATION OF PBRM1 IN MENINGIOMA
#1466DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE BASED ON GENES
#1467CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY
#1468PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#1469COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#1470TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#1471Computational modeling of loss of function based on allelic frequency
#1472METHODS AND MATERIALS FOR ASSESSING AND TREATING OBESITY
#1473DERIVATION OF TROPHOBLAST ORGANOIDS FROM NAIVE HUMAN PLURIPOTENT STEM CELLS
#1474COMPOSITIONS AND METHODS FOR OBTAINING PLANT CULTIVARS WITH DESIRED TERPENE PROFILES BASED ON TERPENE SYNTHASE GENE SELECTION
#1475Molecular marker for identifying trait of efficiency of duck feed utilization based on neuropeptide gene , method and use thereof
#1476Methods for sequencing samples
#1477SYNTHETIC NUCLEIC ACID CONTROL MOLECULES
#1478NOTCH1 BIOMARKERS FOR CANCER THERAPY
#1479ENHANCED SEQUENCING FOLLOWING RANDOM DNA LIGATION AND REPEAT ELEMENT AMPLIFICATION
#1480GENETIC ALTERATIONS ASSOCIATED WITH EOSINOPHILIC ESOPHAGITIS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE
#1481SYSTEMS AND METHODS FOR MITOCHONDRIAL ANALYSIS
#1482Tm-ENHANCED BLOCKING OLIGONUCLEOTIDES AND BAITS FOR IMPROVED TARGET ENRICHMENT AND REDUCED OFF-TARGET SELECTION
#1483SYSTEMS AND METHODS FOR CLASSIFYING THE STATUS OF A TRANSPLANT
#1484SYSTEMS AND METHODS FOR ANALYSIS OF PRESENCE OF MICROORGANISMS
#1485METHOD FOR DETECTING VIRULENT STRAINS OF VENTURIA INAEQUALIS
#1486METHOD AND COMPOSITIONS FOR DRUG RESISTANCE SCREENING
#1487STRATIFICATION AND PROGNOSIS OF CANCER
#1488METHOD FOR PREDICTING THE EFFICIENCY OF A TREATMENT STIMULATING AN IFN-BETA DEPENDENT ADAPTIVE IMMUNE RESPONSE VIA DETECTION OF A SINGLE NUCLEOTIDE POLYMORPHISM
#1489COMPOSITION COMPRISING MUC4 GENE MUTATION DETECTING AGENT FOR PREDICTION OR DIAGNOSIS OF GASTRIC CANCER
#1490METHODS FOR MULTIPLEX DETECTION OF ALLELES ASSOCIATED WITH OPHTHALMIC CONDITIONS
#1491BIOMARKERS
#1492METHODS OF IDENTIFYING MARKERS OF GRAFT REJECTION
#1493METHODS AND COMPOSITIONS FOR INHIBITING AND TREATING NEUROLOGICAL CONDITIONS
#1494A BIOMARKER AND USES THEREFOR
#1495HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF
#1496MOLECULAR MARKERS FOR REDUCED PYRUVATE LEVEL TRAIT IN ALLIUM CEPA
#1497TREATING TUMORS RESULTING IN OR FROM CNS METASTASIS USING MDM2/4 AND CDKN2A INHIBITORS
#1498CANCER DETECTION, MONITORING, AND REPORTING FROM SEQUENCING CELL-FREE DNA
#1499PROGNOSTIC BIOMARKERS FOR CANCER
#1500COMPOSITIONS AND METHODS FOR DETECTING GENE FUSIONS OF RAD51AP1 AND DYRK4 AND FOR DIAGNOSING AND TREATING CANCER